Pfizer/BioNTech’s COVID-19 Vaccine Moves Into Adolescents; Adcomm To Weigh Broader Pediatric Issues

Teenagers
US teenagers 12-15 years old are now eligible to receive Pfizer/BioNTech's COVID vaccine. • Source: Alamy

More from Vaccines

More from Pink Sheet